BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2512633)

  • 21. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.
    Hollander D; Vadheim CM; Brettholz E; Petersen GM; Delahunty T; Rotter JI
    Ann Intern Med; 1986 Dec; 105(6):883-5. PubMed ID: 3777713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between small-intestinal transit rate and intestinal absorption of (14)C-labelled mannitol and (51)Cr-labelled ethylenediaminetetraacetic acid in healthy subjects.
    Madsen JL; Scharff O; Rabol A; Krogsgaard OW
    Scand J Gastroenterol; 1996 Mar; 31(3):254-9. PubMed ID: 8833355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases.
    Andre C; Descos L; Minaire Y
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():113-7. PubMed ID: 2128072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers.
    Ruttenberg D; Young GO; Wright JP; Isaacs S
    Dig Dis Sci; 1992 May; 37(5):705-8. PubMed ID: 1563311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal permeability before and after ibuprofen in families of children with Crohn's disease.
    Zamora SA; Hilsden RJ; Meddings JB; Butzner JD; Scott RB; Sutherland LR
    Can J Gastroenterol; 1999; 13(1):31-6. PubMed ID: 10099814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.
    Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J
    Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease.
    Fotherby KJ; Wraight EP; Neale G
    Scand J Gastroenterol; 1988 Mar; 23(2):171-7. PubMed ID: 3129775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of markers and marker ratios in healthy subjects.
    Blomquist L; Bark T; Hedenborg G; Svenberg T; Norman A
    Scand J Gastroenterol; 1993 Mar; 28(3):274-80. PubMed ID: 8446853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Barrier Dysfunction-A Primary Defect in Twins with Crohn's Disease Predominantly Caused by Genetic Predisposition.
    Keita ÅV; Lindqvist CM; Öst Å; Magana CDL; Schoultz I; Halfvarson J
    J Crohns Colitis; 2018 Nov; 12(10):1200-1209. PubMed ID: 29659773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intestinal permeability in relatives of patients with Crohn's disease].
    Kohout P; Koref P
    Vnitr Lek; 2001 Jun; 47(6):371-4. PubMed ID: 11494882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal permeability in patients with Crohn's disease and their healthy relatives.
    Katz KD; Hollander D; Vadheim CM; McElree C; Delahunty T; Dadufalza VD; Krugliak P; Rotter JI
    Gastroenterology; 1989 Oct; 97(4):927-31. PubMed ID: 2506103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease.
    Teahon K; Smethurst P; Pearson M; Levi AJ; Bjarnason I
    Gastroenterology; 1991 Jul; 101(1):84-9. PubMed ID: 1904381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-steroidal anti-inflammatory agents increase intestinal permeability].
    Auer IO; Habscheid W; Hiller S; Gerhards W; Eilles C
    Dtsch Med Wochenschr; 1987 Jun; 112(26):1032-7. PubMed ID: 3109868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal permeability to [51Cr]EDTA in infectious diarrhea.
    Zuckerman MJ; Watts MT; Bhatt BD; Ho H
    Dig Dis Sci; 1993 Sep; 38(9):1651-7. PubMed ID: 8359077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives.
    Martínez-González O; Cantero-Hinojosa J; Paule-Sastre P; Gómez-Magán JC; Salvatierra-Ríos D
    Br J Rheumatol; 1994 Jul; 33(7):644-7. PubMed ID: 8019793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.
    Söderholm JD; Olaison G; Peterson KH; Franzén LE; Lindmark T; Wirén M; Tagesson C; Sjödahl R
    Gut; 2002 Mar; 50(3):307-13. PubMed ID: 11839706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease.
    Hilsden RJ; Meddings JB; Sutherland LR
    Gastroenterology; 1996 May; 110(5):1395-403. PubMed ID: 8613043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man.
    Elia M; Behrens R; Northrop C; Wraight P; Neale G
    Clin Sci (Lond); 1987 Aug; 73(2):197-204. PubMed ID: 3115663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of immunologic reactions on rat intestinal epithelium. Correlation of increased permeability to chromium 51-labeled ethylenediaminetetraacetic acid and ovalbumin during acute inflammation and anaphylaxis.
    Ramage JK; Stanisz A; Scicchitano R; Hunt RH; Perdue MH
    Gastroenterology; 1988 Jun; 94(6):1368-75. PubMed ID: 3129330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease?
    Jørgensen J; Ranløv PJ; Bjerrum PJ; Diemer H; Bisgaard K; Elsborg L
    Scand J Gastroenterol; 2001 May; 36(5):521-7. PubMed ID: 11346207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.